Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03957954 · ClinicalTrials.gov registry record · Phase 1
Stem Cell Therapy for Limbal Stem Cell Deficiency
A Phase 1 study of Limbal Stem Cell Deficiency, sponsored by University of California, Los Angeles.
- Active
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03957954 is a Phase 1 study of Limbal Stem Cell Deficiency that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03957954, a Phase 1 study of Limbal Stem Cell Deficiency, is active but no longer recruiting, sponsored by University of California, Los Angeles.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase I study will collect preliminary information on the activity and safety of cLSC. We will investigate the ability to manufacture and transplant cLSC onto the cornea successfully at the time of surgery (feasibility), and have cLSC begin to populate the ocular surface (efficacy) without serious adverse events (safety).
Conditions Studied
Interventions
- BIOLOGICAL cLSC
- DEVICE Scleral contact lens (SCL)
Study Locations (1)
California
- University of California - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-09-30 |
| Est. Completion | 2027-04-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03957954
The ClinicalTrials.gov registry entry for NCT03957954 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Limbal Stem Cell Deficiency appearing as the primary indexed condition, and to 2 interventions - of which cLSC is the first listed.
NCT03957954 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03957954 about?
NCT03957954 is a clinical study titled "Stem Cell Therapy for Limbal Stem Cell Deficiency". This phase I study will collect preliminary information on the activity and safety of cLSC. We will investigate the ability to manufacture and transplant cLSC onto the cornea successfully at the time of surgery (feasibility), and have cLSC begin to populate the ocular surface (efficacy) without seri...
What is the current status of trial NCT03957954?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2020-09-30. Estimated completion is 2027-04-30.
What conditions does trial NCT03957954 study?
This clinical trial studies the following conditions: Limbal Stem Cell Deficiency.
What interventions are being tested in trial NCT03957954?
The interventions under investigation include: cLSC (BIOLOGICAL), Scleral contact lens (SCL) (DEVICE).
Who is sponsoring clinical trial NCT03957954?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03957954 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Limbal Stem Cell Deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.